Welcome to Hologic Investor Relations

 Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company’s core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.

The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol HOLX.

Recent and Upcoming Events
Recent News
Aug 24, 2016

Hologic Inc. (Nasdaq: HOLX) applauds Cigna's decision to cover breast tomosynthesis for routine breast cancer screening.1 Effective immediately, this new policy provides Cigna subscribers...

Aug 17, 2016

MARLBOROUGH, Mass., August 17, 2016 -- Hologic Inc. (Nasdaq: HOLX) announced today that a study by University of Pennsylvania researchers, published online in advance of print by Radiology, shows...

Aug 9, 2016

MARLBOROUGH, Mass., August 9, 2016 -- Hologic Inc. (Nasdaq: HOLX) announced today that study results published online in advance of print by Lancet Oncology conclude that Low Dose 3D...

Aug 2, 2016

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at two upcoming investor conferences: The Canaccord Genuity Growth Conference 2016 in Boston on Thursday, August 11 at...

More ›